251
Participants
Start Date
March 15, 2022
Primary Completion Date
August 15, 2022
Study Completion Date
August 15, 2022
Educational Materials on the Cardiovascular Disease in Type 2 Diabetes (CVD-T2D)
Educational Materials will detail the diagnostic tests in question. This CVD-T2D will provide a numerical risk score for the likelihood of patients with type 2 diabetes to have a cardiovascular event in the next 4 years.
Educational Materials on the CVD-T2D and Bundled Metabolic Panel
Educational Materials will detail the diagnostic tests in question.his CVD-T2D will provide a numerical risk score for the likelihood of patients with type 2 diabetes to have a cardiovascular event in the next 4 years. The bundled metabolic scores will provide insight into the patient's current metabolic conditions.
QURE Healthcare, San Francisco
SomaLogic, Inc.
INDUSTRY
Qure Healthcare, LLC
INDUSTRY